Description

n-Ethyl-17-Methyl-Delta(8)-Tetrahydrocannabinol-18-Oic Amide is a synthetic cannabinoid derivative of significant interest in advanced pharmaceutical and biochemical research. This compound matters for its role as a key reference standard and a potential synthetic intermediate in the development of novel therapeutic agents targeting the endocannabinoid system. It is primarily needed by research institutions, pharmaceutical R&D laboratories, and analytical service providers focused on cannabinoid science, medicinal chemistry, and forensic analysis.

Application

• Pharmaceutical Reference Standard: Used for the qualitative and quantitative analysis of cannabinoid-based substances in method development and validation.
• Medicinal Chemistry Research: Serves as a crucial synthetic intermediate or a structural analog in the discovery and development of new cannabinoid receptor modulators.
• Biochemical Assay Development: Employed in in vitro studies to investigate binding affinity and functional activity at cannabinoid receptors (CB1/CB2).
• Forensic Analysis & Toxicology: Acts as an analytical standard for the identification and confirmation of synthetic cannabinoids in forensic and clinical toxicology laboratories.
• Academic Research: Utilized in university and institutional research projects studying the structure-activity relationships (SAR) of tetrahydrocannabinol analogs.
• Quality Control (QC) Testing: Provides a benchmark for purity assessment in the manufacturing and quality assurance of related cannabinoid compounds.

Basic Information

Item	Details
Product Name	n-Ethyl-17-Methyl-Delta(8)-Tetrahydrocannabinol-18-Oic Amide
CAS No.	99760-99-3
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	δ8-THC-18-Oic Acid N-Ethyl Amide; 17-Methyl-δ8-Tetrahydrocannabinol-18-Carboxylic Acid Ethylamide; n-Ethyl-δ8-THC-18-amide; Synthetic Cannabinoid 99760-99-3; Cannabinoid Amide Derivative; (6aR,9R,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-yl Ethylcarbamate (related structural descriptor)
EINECS	Contact for details

Quality Control

Our n-Ethyl-17-Methyl-Delta(8)-Tetrahydrocannabinol-18-Oic Amide is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity, suitable for sensitive research applications. All products undergo rigorous analytical testing, including HPLC, GC-MS, and NMR, to verify identity and purity. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.